Our Story
Every day, our clinical work brings us patients with advanced liver disease. In recent years the hepatitis C elimination program in Georgia changed what we see in the clinic. By introducing broad screening, both for the virus itself and for the condition of the liver, the program uncovered a large number of new cases of hepatocellular carcinoma that in earlier years would often have gone undiagnosed. Referrals to our team rose sharply.
With the patients came CT and MRI studies performed in many different centers. Too often these studies did not meet diagnostic requirements, were carried out without sufficient experience, or contained errors. Working with colleagues abroad, we learned that the same problem exists elsewhere, and that it is probably driven by the overload of radiologists: the number of patients simply exceeds what the available specialists can review with the care each case deserves.
As our experience grew, so did awareness of our work, and patients began to reach us from neighboring countries as well. Conversations with international colleagues showed that they too were working under heavy strain. From these conversations came an idea: to use existing artificial intelligence models to support high-precision image interpretation, diagnosis and treatment planning. In liver disease, radiological examination is of exceptional importance, because the first and most complete diagnosis is very often made this way.
Our aim reaches beyond radiology to molecular and early diagnostic markers. Too often a patient arrives when the disease is already advanced. When hepatocellular carcinoma is detected early, the outlook for treatment is substantially better; when it is detected late, the options are frequently limited.
We therefore decided to found an organization with an international character, open to everyone who shares our concern. The Liver Research Network was established in 2025. Through membership, experience can be shared and a community can grow that is able to solve problems no single person can solve alone. Unlike a university, which works on many problems at once, we devote our research directly to one major problem: liver disease.